Source: Reuters
Thursday, July 02, 2009
Novartis (NOVN.VX)said it expects the U.S Food and Drug Administration to rule on the Swiss pharmaceuticals company's Menveo meningitis vaccine in early 2010 after the regulator sought more information about the treatment.
Full Story